Guardant Health
AJ Chmura is a seasoned professional with extensive experience in assay development and quality control within the biotechnology and healthcare sectors. Currently serving as the Head of Reagents and Quality Control Assay Development at Guardant Health since August 2019, AJ previously held the role of Associate Director of Molecular Diagnostics Assay Development at Thermo Fisher Scientific from 2018 to 2019, successfully leading multidisciplinary teams in developing complex diagnostic systems. Prior to that, AJ spent six years at Siemens Healthcare in various roles, including Senior Manager, where multiple CE-IVD assay products were launched. Earlier career highlights include significant contributions at Pacific Biosciences and Intel, focusing on biochip technologies and innovations in automated systems. AJ holds a PhD in Chemistry from the University of California, Davis, and a Bachelor of Science in Chemistry from SUNY College of Environmental Science and Forestry/Syracuse University.
This person is not in any teams
This person is not in any offices
Guardant Health
14 followers
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.